Nav: Home

New cancer treatment strategy discovered for acute myeloid leukemia

November 01, 2016

University of Hawai'i Cancer Center researchers discovered a novel therapeutic target and treatment strategy for acute myeloid leukemia (AML), a cancer of the blood and bone marrow that normally requires prompt and aggressive treatment.

"New therapeutic targets and drugs are urgently needed to improve AML patient outcomes," said Wei Jia, PhD, researcher in the UH Cancer Center's Cancer Epidemiology Program. Jia continued, "We found an increased use of fructose in AML patients. This unique metabolic feature predicts poor treatment outcomes in patients. Our study provides strong evidence that blocking fructose utilization using a small molecule drug shows dramatic therapeutic benefit for AML treatment."

The conventional regimen for AML treatment is limited. Only about 25 to 30 percent of patients survive for 5 years or more after they are diagnosed.

"This discovery can have a profound impact on cancer treatment outcomes, not just for AML patients, but possibly for many other patients with different types of cancers," said Dr. Randall Holcombe, UH Cancer Center director. "Metabolomics is a unique program at the Center, for which Dr. Jia is an international leader."

The findings published in Cancer Cell highlight the unique ability of AML cells to switch their energy supply from glucose to fructose, when glucose is in short supply. Fructose is the second most abundant blood sugar in the body and is used as a glucose alternative by AML cells in order for the cells to retain energy. After the switch, cancer cells begin to multiply faster.

The study found a treatment potential by stopping the glucose transporter (GLUT 5). This method restricts the AML energy supplies and effectively stops cancer growth. By targeting the GLUT 5, researchers can effectively slow the growth of the cancer cells leading to a new promising treatment for AML patients.

"Our normal cells hardly rely on fructose for growth. This makes the fructose transport in cancer cells an attractive drug target. We are in the process of developing a GLUT5 inhibitor, thus cutting the cancer cells' energy source and eventually killing them. The new GLUT5 inhibitor can potentially be used alone, or in addition to the current chemotherapy drugs to enhance anti-cancer effects," said Jia.
-end-
Leukemia in Hawai'i (Hawai'i Tumor Registry)

Leukemia is one of the top ten most common cancers among women in Hawai'i and the top ten causes of cancer deaths in both men and women.

From 2004 to 2013, the incidence of leukemia significantly increased in Hawai'i men and women.

Cancer Cell publication http://www.cell.com/cancer-cell/fulltext/S1535-6108(16)30441-X

The University of Hawai'i Cancer Center through its various activities, cancer trial patients and their guests, and other visitors adds more than $54 million to the O'ahu economy. This is equivalent to supporting 776 jobs. It is one of only 69 research institutions designated by the National Cancer Institute. Affiliated with the University of Hawai'i at Mānoa, the Center is dedicated to eliminating cancer through research, education, and improved patient care. Learn more at http://www.uhcancercenter.org. Like us on Facebook at http://www.facebook.com/UHCancerCenter. Follow us on Twitter @UHCancerCenter.

University of Hawaii Cancer Center

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.